SCHEMBL30846693

SCHEMBL30846693

CC(C(=O)Nc1ccc2ncccc2c1)C1CCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ POLB P06746 2/20 0.58
▸ MAPT P10636 1/20 0.58
▸ PABPC1 P11940 1/20 0.55
▸ RAB9A P51151 6/20 0.55
▸ CCNE1 P24864 1/20 0.51
▸ CDK2 P24941 1/20 0.51
▸ CDK5 Q00535 1/20 0.51
▸ MAT2A P31153 1/20 0.50
▸ CASP3 P42574 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50
▸ SENP6 Q9GZR1 1/20 0.50
▸ HDAC1 Q13547 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ CRHBP P24387 1/20 0.48
▸ CRHR2 Q13324 1/20 0.48
▸ LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13034819 0.82 NPC1 (0.70) NPC1MEN1KMT2APOLBMAPT
SCHEMBL30846658 0.81 IDO1 (0.47) NPC1MEN1KMT2ARAB9ACASP3
SCHEMBL30846704 0.80 ALDH1A1 (0.46) NPC1MEN1KMT2ARAB9AHTT
SCHEMBL5527183 0.78 NPC1 (0.68) NPC1MEN1KMT2APOLBMAPT
SCHEMBL23758889 0.78 NPC1 (0.63) NPC1MEN1KMT2APOLBMAPT
SCHEMBL30846657 0.77 PRMT3 (0.56) CCNE1CDK2CDK5
SCHEMBL30846683 0.76 IDO1 (0.43) MEN1KMT2AMAPTHTTLMNA
SCHEMBL30846578 0.76 SMARCA2 (0.48) MEN1KMT2AALDH1A1CYP3A4TSHR
SCHEMBL30685742 0.76 TDP1 (0.58) NPC1MEN1KMT2APOLBMAPT
SCHEMBL30846697 0.75 SMARCA2 (0.47) ALDH1A1CYP3A4TSHRKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116910-A1 Heterocycles as WIP1 Inhibitors PMV PHARMACEUTICALS, INC. 2024-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116910-A1 Heterocycles as WIP1 Inhibitors WAPL, WHR1, G3BP1 NPC1 4332/4885MEN1 1607/4885KMT2A 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback